Internal link ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares April 05, 2021 at 08:15 PM UTC
Internal link ProQR Announces Virtual Presentation at American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2021 April 02, 2021 at 08:15 PM UTC
Internal link ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares March 31, 2021 at 02:25 AM UTC
Internal link ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares March 30, 2021 at 08:05 PM UTC
Internal link ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials March 24, 2021 at 11:00 AM UTC
Internal link ProQR to Present Results from Phase 1/2 Trial of QR-421a for Usher Syndrome March 17, 2021 at 11:00 AM UTC
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference March 02, 2021 at 09:30 PM UTC
Internal link ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results February 25, 2021 at 12:00 PM UTC
Internal link ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome February 16, 2021 at 09:30 PM UTC
Internal link ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10 January 07, 2021 at 12:00 PM UTC
Internal link ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference December 18, 2020 at 12:00 PM UTC
Internal link ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference November 18, 2020 at 12:00 PM UTC
Internal link ProQR Announces Third Quarter 2020 Operating and Financial Results November 16, 2020 at 12:00 PM UTC
Internal link ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO) November 02, 2020 at 12:00 PM UTC
Internal link ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer October 05, 2020 at 11:00 AM UTC
Internal link ProQR Announces Virtual Presentations at Scientific Conferences September 24, 2020 at 08:10 PM UTC
Internal link ProQR to Participate in Upcoming Investor Conferences September 03, 2020 at 11:00 AM UTC
Internal link ProQR Announces Second Quarter 2020 Operating and Financial Results August 06, 2020 at 08:30 PM UTC
Internal link ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy July 21, 2020 at 11:00 AM UTC
Internal link ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures July 14, 2020 at 08:30 PM UTC
Internal link ProQR Announces Expert Perspectives Call on LCA10 and Sepofarsen July 13, 2020 at 08:30 PM UTC
Internal link ProQR Announces Expert Perspectives Conference Call Series June 12, 2020 at 11:00 AM UTC
Internal link ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through the Association for Research in Vision and Ophthalmology (ARVO) June 08, 2020 at 11:00 AM UTC
Internal link ProQR Announces First Quarter 2020 Operating and Financial Results May 07, 2020 at 11:00 AM UTC